Azotemia - 25 Studies Found
Completed |
: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS : Atypical Hemolytic Uremic Syndrome : 2009-02-12 : Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) : Atypical Hemolytic Uremic Syndrome : 2009-02-03 : Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
: Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease : Atypical Hemolytic Uraemic Syndrome. : 2009-06-29 |
Completed |
: Rituximab in Patients With Relapsed or Refractory TTP-HUS :
: 2007-09-17 : Drug: Rituximab Rituximab will be administered on weeks 1, 2, 3, and 4 at a dose of 375 mg/m2 per infusi |
Enrolling by invitation |
: The Role of Microparticles as a Biomarker :
|